Clinical trials
Body Weight clinical trials
Below are recruiting body weight clinical trials, each written for real people, not researchers. We’re tracking 101 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06127511Recruiting
Peanut study for brain health and weight in teens
This trial tests whether eating peanuts every day helps thinking, learning, and memory and manages weight and inflammation in young teens.
Barcelona, BarcelonaAges 10–12 - NCT05220709Recruiting
Check fluid balance during pediatric surgery using a body sensor
This study tests whether a noninvasive body monitor (bio impedance) can track fluid balance in children during planned surgery under general anesthesia. If it works well, it may help doctors manage fluids more safely during surgery.
Edegem, AntwerpAges 1 month–16 years - NCT06534567Recruiting
Body changes in young triathletes
This study looks at how the bodies of young triathletes change as they grow. It measures things like muscle, fat, and height to see how training affects development.
San Vicent del Raspeig, AlicanteAges 5–17 - NCT07690176Recruiting
How the body processes sugar after eating by weight group
This study looks at how people with different body weights digest and process sugar after a meal. Participants will eat a special breakfast and have blood and possibly stool tests to track a safe, low-dose radioactive label in the sugar. The goal is to understand why body weight affects sugar metabolism.
WageningenAges 18–65 - NCT06464497Recruiting
Whole foods for teens with obesity pilot study
This study tests whether replacing processed foods with whole foods (like fruits, vegetables, and whole grains) for 8 weeks can help reduce body fat in teens with obesity. Both the teen and a parent or caregiver will learn to prepare and eat healthier meals together.
Nashville, TennesseeAges 10 years+ - NCT07571109RecruitingPhase 3
Weight Loss Medicine for Sleep Apnea on CPAP
This study tests a new injectable medicine (NNC0487-0111) to help people lose weight and improve obstructive sleep apnea (a breathing condition during sleep). You must already be using a CPAP machine (positive airway pressure device) for your sleep apnea.
Gilbert, ArizonaAges 18 years+ - NCT05170919Enrolling by invitationPhase 2
Olanzapine vs mirtazapine for weight loss in advanced cancer
This Phase 2 study tests whether the medicines olanzapine or mirtazapine can help people with advanced cancer who are losing weight without trying. It looks at improving unintentional weight loss when standard cancer care is also ongoing.
Englewood, New JerseyAges 18 years+ - NCT06387901Recruiting
Paclitaxel side effects in breast cancer: activity and body composition
This study looks at how physical activity and body composition affect the side effects of paclitaxel, a chemotherapy drug, in women with stage II or III breast cancer. It aims to help doctors understand who might have more or fewer side effects during treatment.
Brussels, JetteAges 18 years+ - NCT07571005RecruitingPhase 3
Testing a New Weight-Loss Medicine for Sleep Apnea
This study tests whether a new injectable medicine called NNC0487-0111 helps people with excess weight and moderate-to-severe obstructive sleep apnea (a condition where breathing stops repeatedly during sleep) lose weight and improve their sleep apnea—without needing a CPAP machine. The goal is to see if better weight loss can reduce sleep apnea symptoms.
San Diego, CaliforniaAges 18 years+ - NCT07349316Recruiting
Weight and nutrition education for female dieters
This study looks at how weight and nutrition education may affect how you feel about your weight, your body image, and your eating habits. It is for female students at McMaster who are actively trying to lose weight by dieting.
Hamilton, OntarioAges 18 years+ - NCT06602622RecruitingPhase 4
Weight change study for people with HIV switching to DOR/3TC/TDF
This study tests whether switching your HIV medication to a combination called DOR/3TC/TDF can help with weight changes that started after taking another type of HIV drug (integrase inhibitor). It is for people who have gained weight unintentionally and want to see if a different medication helps manage it.
Mexico City, AzcapotzalcoAges 18–80 - NCT03873064Recruiting
Study of BMI and quality of life in adults with solid tumors
This study looks at whether body weight (BMI) is linked to quality of life in people with solid cancers. It may help researchers understand what affects day-to-day well-being during cancer care.
RomeAges 18 years+ - NCT07446998RecruitingPhase 2
Study on enobosarm for weight loss in older adults on semaglutide
This trial tests if adding enobosarm (a muscle-preserving drug) to semaglutide (a weight-loss medication) can help older adults maintain muscle and improve physical function while losing weight. It may be an option for people who are already taking semaglutide and want to prevent muscle loss.
Phoenix, ArizonaAges 65–100 - NCT06937177RecruitingPhase 2
Testing mifomelatide to help maintain weight during chemo
This trial tests an investigational drug called mifomelatide (TCMCB07) to see if it can help people with newly diagnosed colorectal or pancreatic cancer maintain a healthy weight while receiving certain types of chemotherapy. You would give yourself a daily injection under the skin.
Tucson, ArizonaAges 18 years+ - NCT07152509Recruiting
Body Weight's Effect on Activity and Life Quality in Type 2 Diabetes
This study looks at how body weight affects physical activity, balance, and quality of life in people with type 2 diabetes. If you join, the research team will measure your movement abilities and ask about your daily life to see how weight plays a role.
IstanbulAges 18–65 - NCT07710768RecruitingPhase 1
A study on how UBT251 affects certain drugs in people with extra weight
This study tests if a new medicine called UBT251 changes how the body processes caffeine, midazolam (a sedative), and warfarin (a blood thinner). It is for generally healthy adults with a Body Mass Index (BMI) between 27 and 40.
Cypress, CaliforniaAges 18–65 - NCT07670884RecruitingPhase 3
Study of HRS9531 for weight loss in overweight or obese adults
This trial tests an oral medication, HRS9531, to help overweight or obese adults lose weight. It may be an option if you have been unable to lose enough weight through diet and exercise alone.
Zhengzhou, HenanAges 18–75 - NCT06252922Recruiting
How diet changes genetic material in healthy young men
This study looks at how diet can change genetic material in healthy young men. You would eat prepared meals, wear a glucose monitor, and give blood and sperm samples to help researchers understand these effects.
Baton Rouge, LouisianaAges 20–35 - NCT07016815Recruiting
Remote monitoring to adjust heart failure medications
This trial tests whether checking in remotely (telemonitoring) helps doctors adjust heart failure medications more effectively. It is for people newly diagnosed with heart failure who have reduced pumping strength and signs of fluid buildup.
Hong Kong, Hong KongAges 19 years+ - NCT07453823Recruiting
Synbiotic for gut health in overweight adults
This trial tests a combination supplement (a synbiotic) to see if it can improve gut function and gut bacteria in middle-aged and older adults who are overweight and have constipation. If eligible, you take the supplement daily and report how your digestion feels.
Cork, BlackpoolAges 50–70 - NCT07034105Recruiting
Walking patterns in healthy people and stroke survivors
This study compares how people walk on different surfaces and with body weight support. It aims to understand walking differences between healthy individuals and stroke survivors, which could help design better rehab programs.
DhakaAges 18–75 - NCT06426290Recruiting
Predicting success after weight-loss surgery
This study looks at whether a psychological test can help predict who will do well after weight-loss surgery. Researchers are reviewing past test results and surgery outcomes to find patterns.
MoulinsAges 18 years+ - NCT07270497Recruiting
New weight-loss medicines and diet changes in people with excess weight
This study tests whether a newer class of weight-loss medicines (GLP-1 and GIP/GLP-1 analogues) can help people with excess body weight eat healthier and improve their metabolism and behavior. It may be a good option if you are an adult with overweight or obesity and haven't used these medicines recently.
Warsaw, WarszawaAges 18–65 - NCT07456332Enrolling by invitation
Digital lifestyle program for weight loss with HIV and fatty liver
This trial tests a digital lifestyle program (diet and activity coaching) to help people with HIV and fatty liver disease lose weight. It aims to see if the program can reduce body fat in the liver and improve overall health.
L'Hospitalet de Llobregat, BarcelonaAges 18 years+
Hear when a new Body Weight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for body weight?
- Yes. Clin2 currently lists 101 recruiting body weight studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a body weight trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a body weight trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.